Rosmantuzumab
Ipafricept
Vantictumab
Foscenvivint
Prodigiosin
Fz7-21
Foxy-5
Wnt pathway activator 2
BML-284 hydrochloride
Monensin
KY-02327
IWP-3
AV023
TNIK-IN-5
ARUK3001185
NSC668036
PDE5-IN-3
ML243
Wnt/β-catenin agonist 4
Tabituximab barzuxetan (exclude Y90)